Pyxis Oncology (PYXS) Interest & Investment Income (2020 - 2025)
Pyxis Oncology (PYXS) reported Interest & Investment Income of $590000.0 for Q4 2025, up 578.16% year-over-year from $87000.0 in Q4 2024, and down 26.25% on a QoQ basis from $800000.0 in Q3 2025.
Pyxis Oncology (PYXS) has 6 years of Interest & Investment Income data on file, last reported at $590000.0 in Q4 2025.
- Quarterly Interest & Investment Income rose 578.16% year-over-year to $590000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.6 million (up 42.98% YoY) and the FY2025 annual result came in at $3.6 million, up 287.1% from the prior year.
- Interest & Investment Income eased to $590000.0 in Q4 2025 per PYXS's latest filing, from $800000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $1.9 million in Q4 2022 and bottomed at $4000.0 in Q1 2021.
- The 5-year median for Interest & Investment Income is $654500.0 (2022), against an average of $748600.0.
- The widest annual swing landed in 2022, when Interest & Investment Income jumped 26642.86%; it then sank 94.54% in 2024.
- Tracing PYXS's Interest & Investment Income over 5 years: stood at $7000.0 in 2021, then jumped by 26642.86% to $1.9 million in 2022, then declined by 14.85% to $1.6 million in 2023, then slumped by 94.54% to $87000.0 in 2024, then soared by 578.16% to $590000.0 in 2025.
- Per Business Quant, the three latest PYXS Interest & Investment Income figures stand at $590000.0 (Q4 2025), $800000.0 (Q3 2025), and $995000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 305,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Pyxis Oncology | 120.87 Mn | 103.97 Mn | 8.65 Mn | 590,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 590,000.00 |
| Sep 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 995,000.00 |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | 87,000.00 |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 387,000.00 |
| Mar 31, 2024 | 262,000.00 |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 1.71 Mn |
| Jun 30, 2023 | 1.66 Mn |
| Mar 31, 2023 | 1.07 Mn |
| Dec 31, 2022 | 1.87 Mn |
| Sep 30, 2022 | 719,000.00 |
| Jun 30, 2022 | 164,000.00 |
| Mar 31, 2022 | 9,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Sep 30, 2020 | 1,000.00 |